Statistics for 24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non–Small Cell Lung Cancer
Total visits
views | |
---|---|
24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non–Small Cell Lung Cancer | 373 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
Borghaei_2018_24-month.pdf | 472 |
Top country views
views | |
---|---|
United States | 222 |
China | 60 |
Germany | 14 |
Sweden | 6 |
Ukraine | 6 |
Canada | 4 |
Russia | 4 |
Japan | 3 |
United Kingdom | 2 |
Italy | 2 |
South Korea | 2 |
Bulgaria | 1 |
Lithuania | 1 |
Malaysia | 1 |
Philippines | 1 |
Top city views
views | |
---|---|
Wilmington | 58 |
Fairfield | 31 |
Beijing | 21 |
Guangzhou | 14 |
Houston | 13 |
Washington | 13 |
Cambridge | 11 |
Kiez | 9 |
Ann Arbor | 8 |
Jacksonville | 7 |
Kiev | 6 |
White Plains | 6 |
Nanjing | 4 |
Stockholm | 4 |
Chapel Hill | 3 |
Lake Mary | 3 |
Maanshan | 3 |
Brooklyn | 2 |
Frankfurt Am Main | 2 |
Gunzenhausen | 2 |
Indianapolis | 2 |
North Little Rock | 2 |
Overland Park | 2 |
Rome | 2 |
Ryazan | 2 |
San Francisco | 2 |
Santa Clara | 2 |
Seoul | 2 |
Shanghai | 2 |
Toronto | 2 |
Baltimore | 1 |
Changsha | 1 |
Chaoyang | 1 |
Dearborn | 1 |
Gothenburg | 1 |
Hangzhou | 1 |
Klaipeda | 1 |
Kyoto | 1 |
London | 1 |
Mckinney | 1 |
Moscow | 1 |
Motala | 1 |
Mountain View | 1 |
Newport | 1 |
Norristown | 1 |
Norwalk | 1 |
Nürnberg | 1 |
Ottawa | 1 |
Pasig | 1 |
Philadelphia | 1 |
Quincy | 1 |
Reading | 1 |
Saint Petersburg | 1 |
Scottsdale | 1 |
Seattle | 1 |
Seremban | 1 |
Sofia | 1 |
Torrance | 1 |
Toyota | 1 |
Wenzhou | 1 |
Zhongyuan | 1 |